Value-based radiotherapy: A new chapter of the ESTRO-HERO project

Yolande Lievens; Josep-Maria Borras; Cai Grau; Ajay Aggarwal

doi:10.1016/j.radonc.2021.05.007

Value-based radiotherapy: A new chapter of the ESTRO-HERO project

Radiother Oncol. 2021 Jul:160:236-239. doi: 10.1016/j.radonc.2021.05.007. Epub 2021 May 13.

Authors

Yolande Lievens¹, Josep-Maria Borras², Cai Grau³, Ajay Aggarwal⁴

Affiliations

¹ Radiation Oncology Department, Ghent University Hospital and Ghent University, Ghent, Belgium. Electronic address: yolande.lievens@uzgent.be.
² University of Barcelona, IDIBELL, Barcelona, Spain.
³ Department of Oncology and the Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
⁴ Department of Clinical Oncology, Guy's & St Thomas' NHS Trust, and London School of Hygiene and Tropical Medicine, London, UK.

PMID: 33992629
DOI: 10.1016/j.radonc.2021.05.007

Abstract

Radiotherapy interventions are rapidly evolving and improving, holding promise for better patient outcomes, yet at the possible detriment of higher societal costs. The ESTRO-HERO value-based radiotherapy project aims to develop a framework defining and assessing the value of radiotherapy innovations, to support clinical implementation and equitable access, within a sustainable healthcare system.

Keywords: Evidence; Innovation; Outcomes; Radiotherapy; Value-based.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Costs and Cost Analysis
Delivery of Health Care
Humans
Neoplasms* / radiotherapy
Radiation Oncology*
Radiotherapy